Background. Interaction of CDii/CD18 located on neutrophil membranes with its endothelial counterreceptor, intercellular adhesion molecule-1, plays a major role in polymorphonuclear leukocyte (PMN)-mediated endothelial dysfunction and myocardial injury associated with ischemia and reperfusion.
However, PMN-derived L-selectin, which is thought to play an early role in PMN rolling along the vascular endothelium, has not been studied in a setting of myocardial ischemia and reperfusion.
Methods and Results. In this study, we evaluated the effects of a monoclonal antibody against L-selectin, DREG-200, in a feline model of myocardial ischemia (1.5 hours) and reperfusion (4.5 hours). (1 mg/kg) or an isotype-matched IgGl antibody, MAb R3.1, which does not cross-react in cats, was administered as a bolus 10 minutes before reperfusion. In MAb R3.1-treated cats, myocardial ischemia followed by reperfusion resulted in significant coronary vascular endothelial dysfunction, elevated cardiac myeloperoxidase activity indicative of neutrophil accumulation in the ischemic myocardium, and severe myocardial injury. In contrast, administration of DREG-200 at 1 mg/kg significantly attenuated myocardial necrosis (14±4 versus 32±3 expressed as percentage of area at risk, P<.001) and attenuated coronary endothelial dysfunction (P<.01) associated with ischemia/reperfusion. Moreover, myeloperoxidase activity in the ischemic myocardium was significantly lower than MAb R3.1-treated cats (0.4±0.1 versus 0.9±0.2 U/100 mg tissue, P<.05).
Conclusions. These results demonstrate that blocking L-selectin with DREG-200 exerts a significant cardioprotective effect in a feline model of myocardial ischemia and reperfusion, indicating that L-selectin plays a significant role in mediating PMN accumulation and PMN-induced endothelial and myocardial injury after ischemia and reperfusion. (Circulation 1993;88:649-658) KEY WORDS * L-selectin * blood cells * reperfusion * endothelium E arly reperfusion remains the most effective treatment to minimize myocardial injury and improve ventricular function in myocardial ischemia. However, accumulating evidence indicates that reperfusion itself may exert deleterious effects and result in enhanced myocardial injury.1-3 The process of reperfusion injury involves components of a typical inflammatory reaction in which polymorphonuclear leukocytes (PMNs) play an important role.45 Experimental strategies involving prevention of PMN activation6,7 or PMN depletion8 have been shown to reduce myocardial reperfusion injury. Moreover, monoclonal antibodies directed against either the common 1-chain of the neutrophil adhesion glycoprotein complex (ie, CD-18) or an endothelial ligand for CD11/CD18 (ie, intercellular adhesion molecule-1 [ICAM-1i) has been shown to protect the myocardium from reperfusion injury,9410 indicating that interaction of CD11/CD18 with its counterreceptor (eg, ICAM-1) plays an important role in PMN-mediated endothelial and myocardial injury associated with myocardial ischemia and reperfusion.
Another leukocyte adhesion molecule recently named L-selectin (originally LAM-1 or LECAM-1) has been reported to be a major mediator for the initial rolling of PMNs along the endothelium, a process that is essential for subsequent CD-18/ICAM-1-mediated PMN 
Myocardial Ischemia and Reperfusion in the Cat
Adult male cats (weight, 2.5 to 3.9 kg) were anesthetized with sodium pentobarbital (30 mg/kg IV). An intratracheal cannula was inserted through a midline incision, and all cats were placed on intermittent positive-pressure ventilation (Harvard small animal respirator, Dover, Mass). A polyethylene catheter was inserted into the right external jugular vein for supplementary pentobarbital infusion to maintain a surgical plane of anesthesia and for administration of drugs. An additional polyethylene catheter was inserted through the left femoral artery and positioned in the abdominal aorta for measurement of mean arterial blood pressure (MABP) via a Statham P23AC pressure transducer. After a midsternal thoracotomy, the pericardium was opened and a 2-0 silk ligature was placed around the LAD 8 to 10 mm from its origin. Standard lead II of the scalar ECG was used to determine heart rate and ST-segment elevation. The ECG and MABP were continuously recorded on a Grass model 7 At the end of the 6-hour experimental period, the ligature around the LAD was retightened. Thirty milliliters of 0.5% Evans blue dye was injected into the left atrium to stain the area of myocardium that was perfused by the patent coronary arteries. The area at risk was thus determined by negative staining. The heart was rapidly excised and placed in warmed, oxygenated K-H buffer consisting of (in mmol/L): NaCl 118; KCl 4.75; CaCl2. 2H20 2.54; KH2PO4 1.19; MgSO4* 7H20 1.19; NaHCO3 12.5; and glucose 10.0. The LCx and the LAD were isolated and removed for subsequent study of coronary ring vasoactivity. The right ventricle and great vessels were then removed, and the left ventricle was sliced parallel to the atrioventricular groove in 3-mmthick sections. The unstained portion of the myocardium (ie, the total area at risk) was separated from the Evans blue-stained portion of the myocardium (ie, the area not at risk). The area at risk was again sectioned into 1-mm-thick slices and incubated in 0.1% nitroblue tetrazolium in phosphate buffer at pH 7.4 and 37°C for 15 minutes. The tetrazolium dye forms a blue formazan complex in the presence of coenzymes and dehydrogenases. The irreversibly injured or necrotic portion of the myocardium at risk, which did not stain, was separated from the stained portion of the mvocardium (ie, the ischemic but nonnecrotic area). The nonischemic, ischemic nonnecrotic, and ischemic necrotic portions were subsequently weighed, and the results were expressed as the area at risk indexed to the total left ventricular mass, the area of necrotic tissue indexed to the area at risk, and the area of necrotic tissue indexed to the total left ventricular mass. All three portions of myocardial tissue were stored at -700C for subsequent determination of myeloperoxidase (MPO) activity, which was done in a blinded manner.
Determination of Myocardial MPO Activity
The myocardial activity of MPO, an enzyme occurring virtually exclusively in neutrophils, was determined by the method of coronary endothelial cells. However, when unactivated PMNs were added to the coronary segments isolated from the cats subjected to 90 minutes of ischemia and 20 minutes of reperfusion, a threefold to fourfold increase in PMN adherence was observed. Preincubation of PMNs with DREG-200 significantly attenuated this response, but preincubation of PMNs with MAb R3.1 had no effect (Fig 2) . These results indicate that the endothelial ligands for L-selectin are significantly upregulated after 90 minutes of ischemia and 20 minutes of reperfusion, and preincubation of PMNs with an L-selectin antibody blocked the interaction of constitutively expressed L-selectin on PMN surface with the newly expressed ligands on the endothelial surface. Fig  3 illustrates The effects of administration of DREG-200 10 minutes before reperfusion on PMN accumulation and myocardial reperfusion injury were studied in a wellestablished cat myocardial ischemia and reperfusion model. In four sham myocardial ischemia and reperfusion cats, we observed that intravenous administration of DREG-200 (1 mg/kg) had no detectable effect on any of the measured hemodynamic, ECG, or biochemical variables. Thus, DREG-200 at the dose regimen used appeared to be devoid of any significant side effects that could interfere with this study. There were also no significant differences in any of the variables observed initially between the two MI+ R groups of cats. Additionally, there were no significant differences between the sham MI+ R and MI+R groups at any of the hourly pressure-rate index readings, suggesting that administration of DREG-200 exerted no significant effect on systemic hemodynamics and thus did not alter myocardial oxygen demand during myocardial ischemia and reperfusion (Fig 4) . A Accumulation of neutrophils in the ischemic region during reperfusion has been thought to be one of the major mechanisms responsible for reperfusion injury. We measured MPO activity of the three different portions of the myocardium as a marker for neutrophil accumulation in ischemic tissue. These data are summarized in Fig 6. It is evident that in the nonischemic myocardium (ie, area not at risk), MPO activity was * Ml + MAb R3.1 * MI + DREG-200 very low in both MI groups, and there was no significant difference between them, indicating that few neutrophils were present in the nonischemic myocardium. However, MI cats receiving only the control antibody, MAb R3.1, exhibited a marked increase in MPO activity in the ischemic region, developing a sevenfold to ninefold increase in MPO activity in the necrotic myocardium. In contrast, DREG-200-treated ischemic cats exhibited a significantly lower MPO activity in both ischemic nonnecrotic myocardial tissue and necrotic myocardial tissue. These results indicate that adherence and accumulation of neutrophils in ischemic/reperfused myocardium were markedly inhibited by the antibody against L-selectin.
Effect of DREG-200 on Endothelial Dysfunction
Since endothelial dysfunction is an early and critical event in reperfusion injury, we also tested endothelial function by comparing vasoactivity of isolated coronary artery rings with two endothelium-dependent vasodilators, ACh and A-23187, and with an endotheliumindependent vasodilator, acidified NaNO2. Fig 7 illus endothelium-independent vasodilator, NaNO2. In contrast, ACh-induced relaxation of coronary rings obtained from MI+R cats receiving the nonbinding control antibody MAb R3.1 was significantly depressed, whereas ACh-induced relaxation of the rings obtained from cats treated with DREG-200 was significantly preserved. Coronary rings isolated from all groups relaxed fully to the endothelium-independent vasodilator NaNO2. Fig 8 summarizes '26 These adherence receptors are now grouped into three main families, which include the integrin family (eg, CD11/ CD18), the immunoglobulin superfamily (eg, ICAM-1), and the selectin family (eg, L-selectin, P-selectin).27 '28 Present evidence indicates that neutrophil extravasation at sites of acute inflammation is at least a three-step process.14 First, PMNs within the flowing blood must recognize and bind to vascular endothelial cells activated by inflammatory stimuli. The adhesion strength of this initial interaction may be insufficient to overcome intravascular shear force completely, resulting in the characteristic PMN rolling phenomenon.14 The second step of this process involves adhesion strengthening, ensuring a cessation of rolling by PMNs and firm attachment to the endothelium. This is followed by the third step, characterized by transmigration of PMNs through the vascular wall. Numerous studies have shown that the integrin-immunoglobulin adhesion pathway (eg, CD11a/CD18-ICAM-1) is primarily involved in the second step of this process. 19 Previous studies indicate that monoclonal antibodies directed against either the common 13-chain of neutrophil adhesion glycoproteins (ie, CD-18) or a major endothelial ligand for the CD18 complex (ie, ICAM-1) significantly attenuate endothelial dysfunction and myocardial injury after myocardial ischemia and reperfusion.9,'0,39-4' However, the role of selectin-mediated initial PMN-endothelium interaction in reperfusion injury has not been studied. In 40 ,ug/mL of MAb RR1/1, whereas 20 ,ug/mL of MAb R15.7 almost totally inhibited PMN adherence to cat coronary endothelium.9 Alternatively, the affinity of the DREG-200 receptors on PMNs may be lower than that of MAb R15.7 receptors on PMNs.
In conclusion, we have demonstrated that a monoclonal antibody to L-selectin significantly inhibited PMN adherence to ischemic/reperfused coronary endothelium in vitro, and in vivo administration of DREG-200 just before reperfusion significantly attenuated myocardial injury and endothelial dysfunction. To our knowledge, this is the first in vivo study examining the role of L-selectin in myocardial ischemia/reperfusion injury.
These results confirm that the initial L-selectin-mediated interaction of PMNs with the endothelium plays an important role in myocardial ischemia/reperfusion injury.
